![]() |
市场调查报告书
商品编码
1813304
2032 年自动化液体处理市场预测:按产品、组件、技术、应用、最终用户和地区进行的全球分析Automated Liquid Handling Market Forecasts to 2032 - Global Analysis By Product, Component, Technology, Application, End User and By Geography |
根据 Stratistics MRC 预测,全球自动化液体处理市场规模预计在 2025 年将达到 26.4 亿美元,到 2032 年将达到 60.3 亿美元,预测期内的复合年增长率为 12.5%。自动化液体处理是指在实验室环境中使用机器人系统和精密仪器准确且有效率地转移、分配和操作液体。该技术最大限度地减少了人为干预,降低了错误、污染和重复性任务的风险,同时提高了可重复性和通量。自动化液体处理广泛应用于药物发现、基因组学、蛋白质组学和临床诊断等应用领域,可简化涉及微孔盘、试管和其他实验室器皿的复杂工作流程。透过整合先进的软体、感测器和机器人技术,这些系统可以实现精确的体积控制、样品追踪和高通量处理,最终加速研究、提高数据品质并支援大规模实验研究。
实验室自动化的进步
与机器人技术和人工智慧的整合可提高可重复性并提升营运效率。对速度、可扩展性和资料完整性日益增长的需求,正在推动实验室自动化的广泛应用。微型移液技术和非接触式工作流程正在基因组学、蛋白质组学和药物研发领域开闢新的应用。随着自动化成为工作流程现代化的核心,实验室基础设施的转型也正在进行中。系统设计和功能的持续创新将增强其长期的市场相关性。
对熟练人才的需求
培训成本和营运准备往往是小型设施面临的障碍。系统整合和故障排除的复杂性往往会延长部署时间。对专业操作员的要求会增加整体拥有成本。这些营运障碍在资源受限的环境中显着降低了采用率。因此,市场渗透率参差不齐,尤其是在缺乏技术基础设施的地区。
慢性病增多
癌症和糖尿病等疾病需要可扩展且精准的检测平台。自动化技术可确保样本处理的一致性,并加速诊断工作流程。医院和实验室正在投资基础设施,以管理日益增长的患者群体。与基因组学和蛋白质组学工具的整合支持先进的疾病分析。这些因素正在推动市场持续成长。
供应链和营运中断
零件短缺和运输延误阻碍了生产和交付。技术支援和备件供应受限可能会扰乱实验室的运作。疫情或贸易限制等外部衝击会加剧这些脆弱性。实验室效率可能会下降,停机时间也可能增加。这些问题威胁着市场扩张的可靠性。
由于高通量检测、疫苗研发和治疗药物研究的迫切需求,COVID-19疫情显着加速了对自动化液体处理系统的需求。世界各地的实验室都优先考虑自动化,以减少人工劳动、提高准确性并最大程度地降低污染风险。虽然供应链中断最初延迟了设备的供应,但投资的增加和政府的支持促进了市场的采用。此外,生物安全意识的增强以及对更有效率诊断和研究工作流程的需求,也增强了对自动化液体处理技术的长期依赖。
预计硬体部分将成为预测期内最大的部分
由于硬体在自动化液体处理平台中发挥关键作用,预计在预测期内将占据最大的市场份额。机器人模组、移液系统和分配单元构成了这些解决方案的支柱。市场对可自订且强大的硬体配置的需求日益增长。软体整合可在工作流程中提供更强大的控制力和适应性。製造商优先考虑精度和模组化,以满足实验室不断变化的需求。预计未来几年,该领域将继续成为主要的市场驱动力。
预计临床诊断领域在预测期内的复合年增长率最高
由于对快速可靠检测的需求不断增长,临床诊断领域预计将在预测期内实现最高成长率。自动化系统简化了PCR、免疫检测和分子诊断的样本处理。慢性病和感染疾病负担的日益恶化正在推动实验室升级。与数位工具的整合可提高合规性和资料管理水准。分散式检查模式正在提升系统的采用率。该领域预计将在整个医疗保健市场加速成长。
预计在预测期内,北美将占据最大的市场份额,这得益于其成熟的製药、生物技术和研究领域。全自动系统的采用正在不断增加,以提高实验室的精度、通量和可重复性。个人化医疗、药物研发和诊断的需求日益增长,推动着市场扩张。机器人平台和先进配药系统等技术创新正被广泛整合。产业领袖的加入以及对实验室自动化基础设施的持续投资,正推动美国和加拿大市场的稳定成长。
在预测期内,由于对生物技术、製药和学术研究的投资不断增加,预计亚太地区将呈现最高的复合年增长率。对高通量筛检、基因组学和蛋白质组学日益增长的需求正在推动相关技术的采用,尤其是在新兴经济体。自动化可以减少人为错误并提高实验室效率。策略合作和日益增长的医疗基础设施建设正在进一步加速市场发展。在政府措施的支持以及对研发和实验室现代化日益重视的推动下,中国、日本和印度等国家正引领市场发展。
According to Stratistics MRC, the Global Automated Liquid Handling Market is accounted for $2.64 billion in 2025 and is expected to reach $6.03 billion by 2032 growing at a CAGR of 12.5% during the forecast period. Automated liquid handling refers to the use of robotic systems and precision instruments to accurately and efficiently transfer, dispense, and manipulate liquids in laboratory settings. This technology minimizes human intervention, reducing errors, contamination risks, and repetitive strain while enhancing reproducibility and throughput. Widely used in applications such as drug discovery, genomics, proteomics, and clinical diagnostics, automated liquid handling streamlines complex workflows involving microplates, test tubes, and other labware. By integrating advanced software, sensors, and robotics, these systems allow precise volume control, sample tracking, and high-throughput processing, ultimately accelerating research, improving data quality, and supporting large-scale experimental studies.
Advancements in laboratory automation
Integration with robotics and artificial intelligence improves reproducibility and enhances operational efficiency. Rising demand for speed, scalability, and data integrity is prompting widespread adoption of automation across laboratories. Miniaturized dispensing technologies and contactless workflows are unlocking new applications in genomics, proteomics, and drug discovery. Transformation of laboratory infrastructure is underway as automation becomes central to workflow modernization. Continued innovation in system design and functionality is reinforcing long-term market relevance.
Need for skilled personnel
Training costs and operational preparedness often pose barriers for smaller institutions. System integration and troubleshooting complexities tend to prolong deployment timelines. Specialized operator requirements contribute to elevated total cost of ownership. Adoption rates are notably lower in resource-constrained environments due to these operational hurdles. Market penetration is therefore uneven, particularly in regions lacking technical infrastructure.
Growing prevalence of chronic diseases
Diseases like cancer and diabetes demand scalable and precise testing platforms. Automation ensures consistent sample handling and accelerates diagnostic workflows. Hospitals and labs are investing in infrastructure to manage rising patient volumes. Integration with genomic and proteomic tools supports advanced disease profiling. These factors are fueling sustained market momentum.
Supply chain and operational disruptions
Component shortages and shipping delays hinder manufacturing and delivery. Limited access to technical support or spare parts can interrupt lab operations. External shocks such as pandemics or trade restrictions amplify these vulnerabilities. Laboratories may encounter reduced efficiency or downtime. These issues threaten the reliability of market expansion.
The Covid-19 pandemic significantly accelerated the demand for automated liquid handling systems due to the urgent need for high-throughput testing, vaccine development, and research on therapeutics. Laboratories worldwide prioritized automation to reduce manual handling, enhance accuracy, and minimize contamination risks. Supply chain disruptions initially slowed equipment availability, but increased investments and government support boosted market adoption. Additionally, heightened awareness of biosecurity and efficiency in diagnostic and research workflows reinforced the long-term reliance on automated liquid handling technologies.
The hardware segment is expected to be the largest during the forecast period
The hardware segment is expected to account for the largest market share during the forecast period owing to its essential role in automated liquid handling platforms. Robotic modules, pipetting systems, and dispensing units form the backbone of these solutions. Demand is growing for customizable and robust hardware configurations. Software integration enhances control and adaptability across workflows. Manufacturers are prioritizing precision and modularity to meet evolving lab requirements. This segment will remain the primary revenue driver.
The clinical diagnostics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the clinical diagnostics segment is predicted to witness the highest growth rate due to rising demand for fast and reliable testing. Automated systems streamline sample processing for PCR, immunoassays, and molecular diagnostics. The growing burden of chronic and infectious diseases is prompting lab upgrades. Integration with digital tools improves compliance and data management. Decentralized testing models are expanding system usage. This segment is poised for accelerated growth across healthcare markets.
During the forecast period, the North America region is expected to hold the largest market share by well-established pharmaceutical, biotechnology, and research sectors. There is strong adoption of fully automated systems to enhance precision, throughput, and reproducibility in laboratories. Increasing demand for personalized medicine, drug discovery, and diagnostics fuels market expansion. Technological innovations, such as robotic platforms and advanced pipetting systems, are widely integrated. The presence of major industry players and continuous investments in laboratory automation infrastructure contribute to steady growth across the U.S. and Canada.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to increasing investments in biotechnology, pharmaceuticals, and academic research. Growing demand for high-throughput screening, genomics, and proteomics is driving adoption, especially in emerging economies. Automation helps reduce human error and improve laboratory efficiency. Strategic collaborations and rising healthcare infrastructure development are further accelerating market growth. Countries like China, Japan, and India are leading the market, supported by government initiatives and a growing focus on R&D and laboratory modernization.
Key players in the market
Some of the key players in Automated Liquid Handling Market include Thermo Fisher Scientific, Hamilton Company, PerkinElmer, Tecan Group, Agilent Technologies, Danaher Corporation, Formulatrix Inc., Mettler-Toledo International Inc., Becton Dickinson and Company, Aurora Biomed Inc., Eppendorf AG, Analytik Jena AG, Hudson Robotics Inc., Corning Incorporated, Gilson Inc.
In July 2025, Hamilton acquired UK Robotics and Trisonic Discovery to strengthen its integration and dispensing capabilities. The acquisition added dynamic scheduling software (RevoWeb) and acoustic dispensing technologies to Hamilton's portfolio, enabling scalable, contactless liquid handling for genomics, drug development, and diagnostics.
In February 2025, Thermo Fisher launched the Multidrop(TM) Combi+ and Multidrop(TM) Pico(TM) 8 dispensers at SLAS2025. These systems offer ultra-fast microliter and picoliter dispensing for reagents and cell lines, improving precision and throughput in pharmaceutical and biotech liquid handling applications.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.